At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
BioFiberdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
BioFiber and BioFiber-CM Absorbable Biologic Scaffold for Soft Tissue Repair and Reinforcement Post-Market Surveillance Clinical Study
In Brief
An observational study evaluating BioFiber for Full Thickness Rotator Cuff Tear. Completed, enrolled 50 participants across 3 sites in 2 countries.
Detailed Summary
The aim of this study is to collect and report data from a consecutive series of patients implanted with these products as part of a post-market surveillance plan for CE Mark approval in the European Union.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsFull Thickness Rotator Cuff Tear
CountriesFrance, United States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2013
First PostedMay 2013
Primary CompletionApr 2015
TodayJul 2026
First PostedMay 8, 2013
Enrollment StartMar 1, 2013
Primary CompletionApr 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 13.2 years ago
Interventions
BioFiberdevice
Subjects implanted with BioFiber or BioFiber-CM Scaffold